Zanaflex

Zanaflex is a brand name of tizanidine, approved by the FDA in the following formulation(s):

ZANAFLEX (tizanidine hydrochloride - capsule; oral)

• 
  Manufacturer: ACORDA
  
  Approval date: August 29, 2002
  
  Strength(s): EQ 2MG BASE ^[AB], EQ 4MG BASE ^[AB], EQ 6MG BASE ^[RLD][AB]

ZANAFLEX (tizanidine hydrochloride - tablet; oral)

• 
  Manufacturer: ACORDA
  
  Approval date: November 27, 1996
  
  Strength(s): EQ 4MG BASE ^[RLD][AB]

Has a generic version of Zanaflex been approved?

A generic version of Zanaflex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Zanaflex and have been approved by the FDA:

tizanidine hydrochloride capsule; oral

• 
  Manufacturer: APOTEX INC
  
  Approval date: February 3, 2012
  
  Strength(s): EQ 2MG BASE ^[AB], EQ 4MG BASE ^[AB], EQ 6MG BASE ^[AB]

tizanidine hydrochloride tablet; oral

• 
  Manufacturer: ALPHAPHARM
  
  Approval date: December 16, 2003
  
  Strength(s): EQ 4MG BASE ^[AB]


• 
  Manufacturer: APOTEX
  
  Approval date: January 16, 2004
  
  Strength(s): EQ 4MG BASE ^[AB]


• 
  Manufacturer: CARACO
  
  Approval date: September 29, 2003
  
  Strength(s): EQ 4MG BASE ^[AB]


• 
  Manufacturer: COREPHARMA
  
  Approval date: October 11, 2002
  
  Strength(s): EQ 4MG BASE ^[AB]


• 
  Manufacturer: DR REDDYS LABS INC
  
  Approval date: July 3, 2002
  
  Strength(s): EQ 4MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: March 28, 2003
  
  Strength(s): EQ 4MG BASE ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: June 27, 2002
  
  Strength(s): EQ 4MG BASE ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: July 3, 2002
  
  Strength(s): EQ 4MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zanaflex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method of reducing somnolence in patients treated with tizanidine
  Patent 6,455,557
  Issued: September 24, 2002
  Inventor(s): Cara A.; Pellegrini & Paul; Stark
  Assignee(s): Elan Pharmaceuticals, Inc.
  An article and method for reducing somnolence in a patient receiving tizanidine therapy. Tizanidine may be administered in the form of an immediate release multiparticulate composition at or around the time food is consumed. The composition may be packaged in a container for distribution.
  
  Patent expiration dates:
  
  
  • November 28, 2021
    
  
  

See also...

• Zanaflex Consumer Information (Drugs.com)
• Zanaflex Consumer Information (Wolters Kluwer)
• Zanaflex Consumer Information (Cerner Multum)
• Zanaflex Advanced Consumer Information (Micromedex)
• Zanaflex AHFS DI Monographs (ASHP)
• Tizanidine Consumer Information (Drugs.com)
• Tizanidine Consumer Information (Wolters Kluwer)
• Tizanidine Consumer Information (Cerner Multum)
• Comfort Pac w/Tizanidine Advanced Consumer Information (Micromedex)
• Zanaflex Capsule Advanced Consumer Information (Micromedex)
• Tizanidine Advanced Consumer Information (Micromedex)
• Tizanidine Hydrochloride AHFS DI Monographs (ASHP)